Sofosbuvir/Ledipasvir without Ribavirin is effective in the treatment of recurrent hepatitis C infection post liver transplant

被引：0
|
作者：
Shoreibah, Mohamed G. [1 ]
Jones, Deann [1 ]
Orr, Jordan [2 ]
Zhang, Jie [3 ]
Venkata, Krishna V. [4 ]
Massoud, Omar I. [1 ]
机构：
[1] Univ Alabama Birmingham, GI & Hepatol, Birmingham, AL USA
[2] Univ Alabama Birmingham, Internal Med, Birmingham, AL USA
[3] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA
[4] Univ Alabama Montgomery, Internal Med, Montgomery, AL USA
来源：
HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2003
引用
收藏
页码：995A / 996A
页数：2
相关论文
共 50 条
  • [1] Ledipasvir/sofosbuvir without ribavirin is effective in the treatment of recurrent hepatitis C virus infection post-liver transplant
    Mohamed Shoreibah
    Jordan Orr
    DeAnn Jones
    Jie Zhang
    Krishna Venkata
    Omar Massoud
    [J]. Hepatology International, 2017, 11 : 434 - 439
  • [2] Ledipasvir/sofosbuvir without ribavirin is effective in the treatment of recurrent hepatitis C virus infection post-liver transplant
    Shoreibah, Mohamed
    Orr, Jordan
    Jones, DeAnn
    Zhang, Jie
    Venkata, Krishna
    Massoud, Omar
    [J]. HEPATOLOGY INTERNATIONAL, 2017, 11 (05) : 434 - 439
  • [3] Safety and Efficacy of Ledipasvir/Sofosbuvir (LS) with or without Ribavirin (RBV) for Treatment of Recurrent Hepatitis C Infection Post-Liver Transplant.
    Gutierrez, K.
    Scheuermann, J.
    Goldvarg, I.
    Joshi, S.
    Tyson, G.
    Bzowej, N.
    Girgrah, N.
    Anders, S.
    Loss, G.
    Therapondos, G.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 793 - 794
  • [4] Treatment of Hepatitis C with ledipasvir, sofosbuvir with or without ribavirin in post liver transplant patients in an academic center
    Pyrsopoulos, Nikolaos
    Lingiah, Vivek A.
    Sanaka, Sirish
    Fung, Phoenix
    Punnoose, Merlin
    [J]. HEPATOLOGY, 2016, 64 : 810A - 810A
  • [5] SAFETY AND TOLERABILITY OF RECURRENT HEPATITIS C TREATMENT IN POST LIVER AND LIVER/KIDNEY TRANSPLANT PATIENTS TREATED WITH LEDIPASVIR/SOFOSBUVIR WITH AND WITHOUT RIBAVIRIN OR SOFOSBUVIR WITH RIBAVIRIN: SINGLE CENTER EXPERIENCE
    Selim, K.
    Elhazin, B.
    Long, W.
    Karmanova, M.
    Salazar, J.
    Volk, M.
    [J]. JOURNAL OF HEPATOLOGY, 2016, 64 : S788 - S789
  • [6] Treatment of HCV infection in liver transplant recipients with ledipasvir and sofosbuvir without ribavirin
    Pillai, A. A.
    Maheshwari, R.
    Vora, R.
    Norvell, J. P.
    Ford, R.
    Parekh, S.
    Cheng, N.
    Patel, A.
    Young, N.
    Spivey, J. R.
    Mgbemena, O.
    Wedd, J. P.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (11) : 1427 - 1432
  • [7] Outcome of Recurrent Hepatitis C Treatment in Post Liver and Liver/Kidney Transplant Patients Treated with Ledipasavir/Sofosbuvir with and without Ribavirin or Sofosbuvir with Ribavirin: Single Center Experience
    Selim, Khaled
    Elhazin, Bridgeida
    Long, Wen
    Salazar, Jennifer
    Karmanova, Marina
    Volk, Micheal
    [J]. TRANSPLANTATION, 2016, 100 : S124 - S124
  • [8] The safety and efficacy of ledipasvir/sofosbuvir with or without ribavirin in the treatment of orthotopic liver transplant recipients with recurrent hepatitis C: real-world data
    Pyrsopoulos, Nikolaos
    Trilianos, Panagiotis
    Lingiah, Vivek A.
    Fung, Phoenix
    Punnoose, Merlin
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (07) : 761 - 765
  • [9] Sofosbuvir plus ledipasvir for recurrent hepatitis C in liver transplant recipients
    Altraif, Ibrahim Hamad
    [J]. LIVER TRANSPLANTATION, 2017, 23 (04) : 554 - 556
  • [10] Treatment of Patients With Hepatitis C Virus Infection With Ledipasvir-Sofosbuvir in the Liver Transplant Setting
    Abaalkhail, Faisal
    Elsiesy, Hussein
    Elbeshbeshy, Hany
    Shawkat, Mohamed
    Yousif, Sarra
    Ullah, Waheed
    Alabbad, Saleh
    Al-jedai, Ahmed
    Ajlan, Aziza
    Broering, Dieter
    Saab, Sammy
    Al Sebayel, Mohammed
    Al-Hamoudi, Waleed
    [J]. TRANSPLANTATION, 2017, 101 (11) : 2739 - 2745
12345